Oyster Point Pharma: Optimizing KOL Engagement with ³Ô¹Ï±¬ÁÏ Link

¡°³Ô¹Ï±¬ÁÏ Link aggregates information such as publications, clinical trials, congresses, and social posts that allows us to target KOLs and customers that are most relevant to our disease state. It¡¯s been a tremendous help to our team.¡±

- Peter DiNardi, Director, KOL Development, Director of Learning & Development, Oyster Point Pharma

Oyster Point Pharma¡¯s Peter DiNardi discusses how ³Ô¹Ï±¬ÁÏ Link Key People is enabling more effective KOL identification, faster call planning, and better engagement.